Skip to main content
. 2014 Sep 16;13:44. doi: 10.1186/s12941-014-0044-2

Table 4.

Resistance rates by centre of MRSA isolates

% of resistant isolates
Centre (No of isolates) Tetra** Cipro Line F. Acid Vanco Kana Erythro Linco Genta
Aydın (15) 86.6 100 0 0 0 100 80 60 93.3
İzmir (17)A* 94.1 100 0 5.8 0 100 52.9 64.7 88.2
İzmir (22)B* 95.4 100 0 9.1 0 90.9 72.7 63.6 90.9
Afyon (23) 91.3 86.9 0 21.7 0 86.9 21.7 26.1 82.6
Manisa (23) 95.6 86.9 0 0 0 95.6 69.5 56.5 91.3
Van (42) 95.2 97.6 0 2.4 0 95.2 4.7 2.4 92.8
Trabzon (54) 88.9 74.1 0 12.9 0 70.3 52.7 40.7 68.5
Samsun (51) 98 94.1 0 7.8 0 92.1 45.1 31.3 90.2
Ankara (31) 100 100 0 0 0 96.7 58 41.9 80.6
Konya (28) 92.8 96.4 0 10.7 0 96.4 89.3 46.2 92.8
İstanbul (55) 52.7 96.3 0 3.6 0 96.3 56.3 58.2 96.3
Edirne (36) 88.8 88.8 0 8.3 0 88.8 50 41.6 88.8
Toplam (397) 88.2 92.2 0 8.1 0 91.4 56.7 42.3 90.2

*A: Katip Celebi University Bozyaka Hospital, B: Izmir Atatürk State Hospital.

**Tetra, Tetracycline; Cipro, Ciprofloxacin; Line, Linezolid; F. Acid, Fusidic Acid; Vanco, Vancomycin; Kana, Kanamycin, Erythro, Erythromycin; Linco, Lincomycin; Genta; Gentamycin.